The agency’s decision to conceal drug names on inspection reports has prevented doctors, pharmacists and patients from ...
The preclinical drug from Vanqua Bio is designed to inhibit “C5aR1,” a part of the immune system that regulates inflammation.
Ontario Premier Doug Ford said he will pause the ad on Monday "so that trade talks can resume." ...
Amazon S3 on MSN
Top mistakes made by people with 401(k)'s
SCOTUS majority declines to give ‘barest form of mercy’ as National Guard ruling awaits Bari Weiss' First Weeks at CBS News: ‘60 Minutes' Miss, Hunt for New Talent, Concerns Over Union Status at Free ...
Discover Merck & Co., Inc.'s Q3 earnings outlook as Keytruda's patent nears expiry. Click for my updated look at MRK stock ...
Scienture stock surged 355% on the commercial launch of Arbli, the first FDA-approved liquid losartan, backed by extensive distribution deals.
In this week’s edition of The Prototype, we look at the man trying to build the next Tesla, a retinal implant that restores ...
According to Defense Secretary Pete Hegseth, the strike killed two people, bringing the death toll from all the strikes to at ...
Sometimes the biggest moments at a conference happen backstage. At the annual STAT Summit, that kind of moment involved a ...
Ontario Premier Doug Ford said the ad will still run during the World Series between the Blue Jays and Dodgers.
Biogen agreed to license a preclinical treatment of inflammatory diseases from Vanqua Bio, giving it exclusive worldwide rights to the drug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback